Who is sponsoring NCT07351890?

NCT07351890 is sponsored by Run-hua Li.

What drugs are being tested in NCT07351890?

Interventions in NCT07351890: Endoscopic Ultrasound (EUS) Assessment.

What condition does NCT07351890 study?

NCT07351890 studies Colorectal Subepithelial Lesions.

Is NCT07351890 still recruiting?

NCT07351890 is currently completed. Last updated 20 January 2026.

Last reviewed 2026-01-20 · How we verify

NCT07351890

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Diagnostic Accuracy of EUS for Colorectal Submucosal Masses

Completed Last updated 20 January 2026

What this trial tests

trial testing Endoscopic Ultrasound (EUS) Assessment in Colorectal Subepithelial Lesions in 270 participants. Completed in 1 October 2023.

Timeline

1 January 2015

Primary endpoint
1 October 2023

1 October 2023

Quick facts

Lead sponsor	Run-hua Li
Status	Completed
Study type	OBSERVATIONAL
Enrollment	270
Start date	1 January 2015
Primary completion	1 October 2023
Estimated completion	1 October 2023
Sites	1 location across China

Drugs / interventions tested

Endoscopic Ultrasound (EUS) Assessment

Conditions studied

Colorectal Subepithelial Lesions — all drugs for Colorectal Subepithelial Lesions →

Sponsor

Run-hua Li

Who can join

Eligibility, any sex, with Colorectal Subepithelial Lesions. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the diagnostic accuracy of endoscopic ultrasound (EUS) for colorectal submucosal tumors/lesions (SMTs/SELs) and to identify factors associated with correct EUS diagnosis. Using cases with histopathologic confirmation as the reference standard, EUS-based preoperative diagnoses will be compared with final pathology to estimate overall accuracy and accuracy across different lesion types. Potential influencing factors-including lesion location, size, echogenicity, layer of origin, image quality, operator experience and training, and EUS equipment/probe type-will be analyzed to determine independent predictors of diagnostic concordance. The findings are expected to inform optimization of EUS examination and interpretation for colorectal submucosal lesions, thereby improving clinical decision-making and overall quality of care.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Run-hua Li trials

Trials by the same sponsor.

NCT07374822 — Real-World Study of Helicobacter Pylori Eradication Success and Its Determinants · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07351890 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Run-hua Li
Last refreshed: 20 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07351890.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing